functional dyspepsia and gastroesophageal reflux diseases
Conditions
Interventions
Roxatidine 75mg
Sponsors
Gastroenterology Division, Yokohama City University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The patient with epigastric symptoms before endoscopy.
Exclusion criteria
Exclusion criteria: 1)Patient who has ulcer [**] 2)Patient who receives operation of gut excision and vagectomy 3)Patient who has diseases of serious renal damage, hepatic toxicit, and blood trouble, etc. 4)Patient who has malignant tumor 5)Patient who has possibility of pregnant woman and pregnancy 6)Patient who has change in dosage taking NSAID and gut movement activating medicine, and before and after experimental drug taking 7)Patient who is administering antsecratory medcines such as PPI and H2RA (H2RA needs the doing taking medicine period for PPI for two weeks or more for one week or more for the patient who had been administered before. ) 8)Patient who has allergic history for experimental roxatidine 9)Patient who assumes judgment from doctor when it is improper as object of this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| epigastric symptoms | — |
Countries
Japan
Contacts
Public ContactMasahiko Inamori
Yokohama City University Graduate School of Medicine Gastroenterology Division
Outcome results
None listed